Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Experts tie chemotherapy to slight increase in AML risk
Patients who underwent chemotherapy for non-Hodgkin lymphoma and esophageal, prostate and cervical cancers had an increased risk of developing acute myeloid leukemia, a study found. However, chemotherapy was associated with lower AML risk in ovarian cancer and myeloma, researchers said.
HealthDay News (2/14)
Or we can send an email on your behalf